JOO SCHMIDT: Open Payments
NPI 1972158541 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 14 payments from 9 companies in 2025. Trend: 2023 $529 · 2024 $119 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. | 3 | $102 |
| SOBI, INC | 3 | $90 |
| PharmaEssentia USA Corporation | 2 | $57 |
| Celgene Corporation | 1 | $34 |
| Astellas Pharma US Inc | 1 | $31 |
| Blueprint Medicines Corporation | 1 | $28 |
| Incyte Corporation | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Adaptive Biotechnologies Corporation | 1 | $15 |
Products named: Vonjo, BESREMI, REBLOZYL, Cresemba, AYVAKIT, JAKAFI, DANZITEN, clonoSEQ.
Industry payments across TX — which companies pay providers there.
